KDM1B and cancer: Based on the findings from Musella et al. and studies on the polarisation of immune cells in TME, it is understood that during immunosurveillance, the interferons in TME trigger upregulation of KDM1B in dormant cancer cells, which, in turn, remodels the former through immunoediting, changing its phenotype characteristics to protumorigenic.